---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-056908"
form_type: "8-K"
ticker: "OPRX"
cik: "0001448431"
company_name: "OptimizeRx Corp"
filed_at: "2025-06-24T23:59:59+00:00"
generated_at: "2026-05-18T22:17:26.442233+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# CEO Steve Silvestro appointed to OptimizeRx Board effective June 20, 2025

## Summary
- Board increased to six members and appointed CEO Stephen Silvestro as director.
- Silvestro has served as CEO since March 2025, previously interim CEO from January 2025.
- Appointment effective through the 2026 annual meeting; no financial impact disclosed.

## SEC filing metadata
- accession: 0001213900-25-056908
- form_type: 8-K
- ticker: OPRX
- cik: 0001448431
- company_name: OptimizeRx Corp
- filed_at: 2025-06-24T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1448431/000121390025056908/0001213900-25-056908-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1448431/000121390025056908/ea0246602-8k_optimize.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-056908
- JSON: https://secwatch.observer/filing/0001213900-25-056908.json
- Plain text: https://secwatch.observer/filing/0001213900-25-056908.txt

## Key facts
- Executive change
  Stephen Silvestro was appointed as director at OptimizeRx Corp.
  - Action: appointed
  - Role: director
  source text: appointed the Company’s CEO Stephen Silvestro to serve as a director
  evidence_url: https://www.sec.gov/Archives/edgar/data/1448431/000121390025056908/0001213900-25-056908-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.